Bloodstream infections caused by carbapenem-resistant Acinetobacter baumannii: clinical features, therapy and outcome from a multicenter study

In recent years, bloodstream infections (BSI) due to multidrug-resistant (MDR) gram-negative bacteria such as Acinetobacter baumannii (AB) have been increasingly observed among hospitalized patients admitted to the intensive care unit (ICU), surgical and medical wards.1 –3 MDR-AB has been defined one of the top priority pathogens by the World Health Organization4,5; specifically, in Italy an increased incidence of MDR-AB was observed in the last years.6

Source: Journal of Infection - May 27, 2019 Category: Infectious Diseases Authors: Alessandro Russo, Matteo Bassetti, Giancarlo Ceccarelli, Novella Carannante, Angela Raffaella Losito, Michele Bartoletti, Silvia Corcione, Guido Granata, Antonella Santoro, Daniele Roberto Giacobbe, Maddalena Peghin, Antonio Vena, Francesco Amadori, Franc Source Type: research